In 2020, West Virginia launched a pilot program to subsidize the drugs for public employees
Patients hold overwhelming demand for GLP-1s, but access (supply + list price cost) creates constraints Employers and payors are grappling with benefit design and coverage access qualifications for GLP-1s (e.g., limiting to diabetes patients)
Li Q, Shao S, Zhu Z, Chen J, Hao J, Bai Y, Li B, Dang E, Wang G
Love it So happy to have this as I detox from mold and other issues
On average, people taking injectable Semaglutide with Henry lost ~18% of their body weight in a year.1 Everyone is different and your results will vary depending on your medication, dosing, medical history, and other factors like diet and exercise